Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries CinCor Pharma, Inc. - Common Stock (NQ: CINC ) N/A UNCHANGED Last Price Updated: 4:00 PM EST, Feb 23, 2023 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about CinCor Pharma, Inc. - Common Stock < Previous 1 2 3 4 Next > Stocks That Hit 52-Week Lows On Friday December 02, 2022 On Friday, 72 companies hit new 52-week lows. Via Benzinga Hibbett, Enfusion And Some Other Big Stocks Moving Lower On Tuesday November 29, 2022 U.S. stocks traded lower, with the Dow Jones dropping over 100 points on Tuesday. Here are some big stocks recording losses in today’s session. Via Benzinga CinCor Pharma Sinks After Disappointing Data From Hypertension Trial November 28, 2022 Via Benzinga Expert Ratings for CinCor Pharma October 28, 2022 Analysts have provided the following ratings for CinCor Pharma (NASDAQ:CINC) within the last quarter: Via Benzinga Where CinCor Pharma Stands With Analysts October 28, 2022 Within the last quarter, CinCor Pharma (NASDAQ:CINC) has observed the following analyst ratings: Via Benzinga 12 Health Care Stocks Moving In Tuesday's Intraday Session November 29, 2022 Via Benzinga Why Shares Of Chinese Companies Are Trading Higher? Here Are 45 Stocks Moving In Tuesday's Mid-Day Session November 29, 2022 Gainers Otonomy, Inc. (NASDAQ: OTIC) shares surged 74.2% to $0.1866. Otonomy recently posted a Q3 loss of $0.18 per share. Via Benzinga US Stocks Edge Higher Following Monday's Sell-Off November 29, 2022 U.S. stocks traded slightly higher this morning, with the Dow Jones gaining more than 30 points on Tuesday. The blue-chip index dropped around 500 points on Monday. Via Benzinga What 4 Analyst Ratings Have To Say About CinCor Pharma October 28, 2022 Within the last quarter, CinCor Pharma (NASDAQ:CINC) has observed the following analyst ratings: Via Benzinga Expert Ratings for CinCor Pharma September 09, 2022 Within the last quarter, CinCor Pharma (NASDAQ:CINC) has observed the following analyst ratings: Via Benzinga 4 Analysts Have This to Say About CinCor Pharma August 22, 2022 CinCor Pharma (NASDAQ:CINC) has observed the following analyst ratings within the last quarter: Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For November 29, 2022 November 29, 2022 Via Benzinga FedEx To Rally Over 25%? Here Are 10 Other Price Target Changes For Tuesday November 29, 2022 Keybanc lowered Salesforce, Inc. (NYSE: CRM) price target from $210 to $200. . Keybanc analyst Michael Turits maintained an Overweight rating on the stock. Salesforce shares gained 0.5% to $154.45 in... Via Benzinga Dow Tumbles 450 Points; S&P 500 Falls 1.5% November 28, 2022 U.S. stocks traded lower toward the end of trading amid protests over COVID-19 restrictions in China. The Dow Jones dropped more than 450 points on Monday. Via Benzinga Why Taboola Shares Are Trading Higher By Around 53%? Here Are 53 Stocks Moving In Monday's Mid-Day Session November 28, 2022 Gainers Taboola.com Ltd. (NASDAQ: TBLA) shares gained 52.5% to $2.8050 after the company announced it entered into a 30-year exclusive commercial agreement with Yahoo. Via Benzinga 12 Health Care Stocks Moving In Monday's Intraday Session November 28, 2022 Via Benzinga Stocks Stumbling After Thanksgiving Week November 28, 2022 The Dow Jones Industrial Average is extending its premarket losses, down 265 points at midday, as protests in China over the country's zero-Covid policy weigh on investor sentiment globally. Via Talk Markets Dow Tumbles Over 200 Points; Axsome Therapeutics Shares Spike Higher November 28, 2022 U.S. stocks traded lower midway through trading, with the Dow Jones dropping more than 200 points on Monday. Via Benzinga CinCor Pharma, Anavex Life Sciences And Some Other Big Stocks Moving Lower On Monday November 28, 2022 U.S. stocks traded lower, with the Dow Jones dropping over 200 points on Monday. Here are some big stocks recording losses in today’s session. Via Benzinga US Stocks Start Week On Lower Note, Dow Drops Over 100 Points November 28, 2022 U.S. stocks traded lower this morning, with the Dow Jones dropping more than 100 points on Monday. Via Benzinga 12 Health Care Stocks Moving In Monday's Pre-Market Session November 28, 2022 Via Benzinga Correcting and Replacing: CinCor Reports Third Quarter Financial Results and Provides Corporate Update November 04, 2022 From CinCor Pharma Inc Via GlobeNewswire CinCor Reports Third Quarter Financial Results and Provides Corporate Update November 03, 2022 From CinCor Pharma Inc Via GlobeNewswire Benzinga's Top Ratings Upgrades, Downgrades For October 28, 2022 October 28, 2022 Upgrades Via Benzinga 3 Soaring Biotech Stocks That Could Climb Much Higher October 20, 2022 These drugmakers have bucked the overall market's downward trend this year and expectations are still high. Via The Motley Fool 12 Health Care Stocks Moving In Tuesday's After-Market Session September 20, 2022 Gainers CinCor Pharma (NASDAQ:CINC) shares moved upwards by 19.5% to $33.0 during Tuesday's after-market session. The market value of their outstanding shares is at $1.4 billion. Via Benzinga Analyst Ratings for CinCor Pharma September 09, 2022 Over the past 3 months, 5 analysts have published their opinion on CinCor Pharma (NASDAQ:CINC) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a... Via Benzinga Where CinCor Pharma Stands With Analysts September 09, 2022 Over the past 3 months, 5 analysts have published their opinion on CinCor Pharma (NASDAQ:CINC) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a... Via Benzinga 10 Biotech Stocks Are Up 40% Or More This Year, Including Karuna, Axsome And Others August 29, 2022 These names are benefitting from M&A, clinical data and promising regulatory actions. Via Investor's Business Daily Benzinga's Top Ratings Upgrades, Downgrades For August 22, 2022 August 22, 2022 Upgrades Via Benzinga < Previous 1 2 3 4 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.